Browse the evidence

Chronic, low-grade inflammation (inflamm-aging) driven by cytokine dysregulation, oxidative stress, and senescent cells is a primary mechanism underlying aging and age-related diseases such as cardiovascular disease, diabetes, and neurodegeneration.

Focus on lifestyle factors that reduce chronic inflammation: adopt a Mediterranean-style diet rich in omega-3s, engage in regular exercise to upregulate autophagy, and manage stress. These approaches support the body's natural resolution of inflammation rather than just suppressing symptoms.

Senescent cells contribute to aging and age-related diseases through the Senescence-Associated Secretory Phenotype (SASP), which promotes a pro-inflammatory milieu.

While direct 'senolytic' treatments are not yet standard, lifestyle factors that reduce cellular stress (exercise, healthy diet) may help minimize the accumulation of senescent cells.

Epigenetic clocks (DNAmAge) are currently the most robust biological age predictors, strongly correlating with chronological age and independently predicting all-cause mortality, cancer mortality, and various aging phenotypes such as frailty and cognitive decline.

Chronological age is not your destiny. Biomarkers like DNA methylation (epigenetic clocks) show that your body's biological state can differ significantly from your birth year. While you cannot change your birth date, these markers suggest that your health trajectory is influenced by factors like inflammation, immune function, and lifestyle. Monitoring these biological ages (where available) may offer more insight into your health risks than age alone, highlighting the importance of maintaining metabolic health and managing inflammation to potentially slow biological aging.

The accumulation of senescent cells and their Secretory Phenotype (SASP) drives chronic inflammation (inflammaging) and contributes to age-related tissue dysfunction.

Chronic low-grade inflammation is a key driver of aging. Research suggests that this inflammation is partly caused by the accumulation of senescent cells. Therapies that clear these cells have been shown to reduce inflammatory markers in animal models.

Chronic low-grade inflammation (inflammaging) is a key pathophysiologic association in aging, driven by oxidative stress-induced redox imbalance and the accumulation of senescent cells.

Recognize that chronic, low-grade inflammation is a key driver of aging. Strategies to reduce inflammation, such as managing stress, maintaining a healthy weight, and ensuring adequate sleep, may help mitigate age-related degeneration.

Dietary fiber fermentation by gut microbiota produces short-chain fatty acids (SCFAs) which activate specific receptors (GPR41, GPR43, GPR109A) to regulate energy expenditure, lipid homeostasis, and inflammation.

Prioritize diverse sources of dietary fiber to support gut bacteria that produce SCFAs. These microbial byproducts act as signals to regulate your metabolism and reduce inflammation, offering benefits beyond simple caloric intake.

Non-caloric artificial sweeteners (NAS) induce glucose intolerance by altering gut microbiota composition, and these effects can be reversed by antibiotics.

Be cautious with non-caloric artificial sweeteners, as they may negatively impact glucose tolerance by altering your gut microbiome. Opt for whole foods or unsweetened beverages when possible.

DNA methylation clocks are highly accurate molecular correlates of chronological age in humans and vertebrates, but their ability to quantify biological aging rates and test longevity interventions is currently limited by challenges in distinguishing chronological from biological components and understanding underlying mechanisms.

DNA methylation clocks are currently best used as precise tools for estimating chronological age, particularly in forensic or large-scale epidemiological contexts. Their use for evaluating anti-aging interventions is still experimental and requires specialized, tissue-specific clocks rather than general 'pan-tissue' clocks. Individuals should not rely on current commercial epigenetic age tests for making definitive health decisions regarding longevity interventions, as the scientific community acknowledges significant unresolved challenges in distinguishing true biological aging from chronological age effects.

Gut microbiota fermentation of unabsorbed starch and soluble dietary fiber into short-chain fatty acids (SCFAs) provides approximately 10% of daily dietary energy for the host and serves as the primary fuel source for colonocytes, thereby regulating energy homeostasis and metabolic efficiency.

To support your gut's energy regulation, prioritize foods rich in unabsorbed starch and soluble fiber (like resistant starch, oats, legumes). Your gut bacteria ferment these into SCFAs, which provide about 10% of your daily energy needs and fuel your colon cells. This is a natural metabolic process that supports overall energy homeostasis.

Antibiotic administration, particularly broad-spectrum fluoroquinolones, disrupts the gut microbiome by reducing secondary bile acid-producing bacteria (e.g., C. scindens), which removes the inhibition on Clostridium difficile vegetative growth and leads to infection.

Be cautious with broad-spectrum antibiotics, especially fluoroquinolones, as they can wipe out the specific bacteria that produce secondary bile acids. These bile acids normally inhibit C. difficile. If you must take antibiotics, discuss probiotic or dietary strategies to support your gut microbiome afterward, as this disruption is a primary cause of post-antibiotic diarrhea and CDI.

Specific gut microbiota species and their metabolites (SCFAs, bile acids) actively maintain intestinal barrier integrity and exert anti-inflammatory effects.

Consuming a diet rich in diverse fibers supports the growth of beneficial bacteria that produce SCFAs and strengthen the gut barrier. This is a key strategy for reducing systemic inflammation and supporting metabolic health.

High-fat diets and saturated fatty acids can disrupt intestinal barrier integrity and promote systemic inflammation via TLR4 activation and bile acid alterations.

Limiting saturated fat intake and focusing on unsaturated fats can help maintain gut barrier integrity and reduce systemic inflammation, especially in individuals prone to metabolic issues.

Bacterial cross-feeding is essential for the production of butyrate and propionate from prebiotic substrates like inulin and resistant starch.

A diverse diet with various types of fibers supports a diverse microbiome, which enables cross-feeding. This natural process is more effective at producing beneficial SCFAs than consuming single prebiotic supplements in isolation.

A specific outer membrane protein from Akkermansia muciniphila, Amuc_1100, mediates the metabolic benefits by activating Toll-Like Receptor 2 (TLR2).

The benefits of Akkermansia muciniphila are driven by its outer membrane protein Amuc_1100, which interacts with the immune system (TLR2). This suggests that future therapies might use just this protein rather than the whole bacterium.

Cardiovascular health, specifically arterial pulsatility driven by cardiac output, is a mechanical prerequisite for effective glymphatic fluid transport; conditions like hypertension and heart failure reduce this pulsatility, impairing waste clearance and increasing dementia risk.

Maintain cardiovascular health to support the mechanical force (arterial pulsatility) that drives brain waste clearance. Manage blood pressure, treat heart conditions, and stay physically active to ensure your heart pumps effectively, which in turn helps your brain clear out harmful proteins.

NAD+ metabolism regulates physiological processes and its deficiency contributes to metabolic diseases, cancer, aging, and neurodegeneration.

Maintaining healthy NAD+ levels is crucial for preventing age-related diseases. While the paper focuses on mechanisms, lifestyle factors like exercise and caloric restriction are known to support NAD+ homeostasis. Consider discussing NAD+ precursors with a healthcare provider if you are interested in therapeutic interventions.

NAD+ deficiency contributes to a spectrum of diseases including metabolic diseases, cancer, aging and neurodegeneration disorders.

Maintaining healthy NAD+ levels is crucial for preventing age-related diseases. While the paper focuses on mechanisms, lifestyle factors like exercise and caloric restriction are known to support NAD+ homeostasis. Consider discussing NAD+ precursors with a healthcare provider if you are interested in therapeutic interventions.

Ectopic lipid accumulation in the liver and skeletal muscle is a primary cause of insulin resistance, mediated by lipid metabolites like diacylglycerol (DAG) and ceramides which interfere with insulin signaling pathways.

Focus on reducing fat stored in your liver and muscles, not just overall weight. This can be achieved through modest weight loss, exercise, or specific medical treatments for conditions like NAFLD. Reducing intrahepatic triglycerides dramatically reverses insulin resistance.

Diacylglycerol (DAG) accumulation at the plasma membrane, specifically the sn-1,2 stereoisomer, activates Protein Kinase C (PKC) isoforms (PKCε in liver, PKCθ in muscle), which inhibits insulin signaling.

Not all fat is bad for insulin signaling. It is the specific type and location of fat (DAG at the cell membrane) that blocks insulin. Reducing this specific lipid fraction improves sensitivity.

The transition from metabolically healthy obesity (MHO) to metabolically unhealthy obesity (MUO) is common, with approximately 30-50% of MHO individuals developing metabolic abnormalities over 3-12 years.

Your 'healthy' metabolic status is not guaranteed to last. Studies show that 30-50% of people with MHO develop diabetes or heart risks within a decade. You should monitor your metabolic markers regularly and maintain physical activity to delay or prevent this transition.

The association between ultra-processed food consumption and cancer risk is not mediated by standard nutritional factors like lipid, sodium, or carbohydrate intake.

This study suggests that the cancer risk associated with ultra-processed foods is not just because they are high in fat, sugar, or salt. Even when accounting for these nutritional factors, the risk persists. This implies that the processing methods, additives, and contaminants in these foods may play a significant role in increasing cancer risk, independent of their basic nutritional content.

Lower LDL-cholesterol levels causally protect against type-2 diabetes, which may explain the increased T2D risk observed with statin therapy.

If you are taking statins for cholesterol, be aware that they may slightly increase your risk of type-2 diabetes. Regular monitoring of blood sugar levels is advisable. Do not stop medication without consulting your doctor, as the cardiovascular benefits often outweigh this risk.

Obesity-induced chronic low-grade inflammation in adipose tissue acts as a causal mechanism for insulin resistance and type 2 diabetes mellitus.

In obesity, fat tissue doesn't just store energy; it actively releases inflammatory signals that block insulin from working. This inflammation is a key driver of type 2 diabetes risk. While weight loss helps, the inflammatory state itself is a direct cause of metabolic dysfunction, suggesting that managing inflammation is crucial for metabolic health.

Age-related diseases (ARDs) and geriatric syndromes are not distinct entities but represent accelerated aging trajectories driven by the same molecular mechanisms as normal aging.

Focus on interventions that target shared aging mechanisms (like chronic inflammation and oxidative stress) rather than just treating individual diseases as they appear. This approach, known as geroscience, suggests that slowing aging may prevent or delay multiple age-related conditions simultaneously.